Total Payments
$9,817
2024 Payments
$1,883
Companies
40
Transactions
330
Medicare Patients
14,976
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$8,458 (86.2%)
Other$1,280 (13.0%)
Consulting$28.17 (0.3%)
Travel$26.05 (0.3%)
Education$24.25 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,458 | 320 | 86.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,280 | 3 | 13.0% |
| Consulting Fee | $28.17 | 1 | 0.3% |
| Travel and Lodging | $26.05 | 3 | 0.3% |
| Education | $24.25 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $1,425 | 12 | $0 (2022) |
| PFIZER INC. | $1,221 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $657.81 | 27 | $0 (2024) |
| Merck Sharp & Dohme LLC | $514.06 | 27 | $0 (2024) |
| HEARTFLOW, INC. | $477.14 | 5 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $441.18 | 24 | $0 (2024) |
| ABIOMED | $424.15 | 4 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $414.96 | 24 | $0 (2024) |
| Amarin Pharma Inc. | $413.90 | 17 | $0 (2022) |
| Edwards Lifesciences Corporation | $376.23 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,883 | 64 | Inari Medical, Inc. ($186.24) |
| 2023 | $896.96 | 28 | PFIZER INC. ($200.72) |
| 2022 | $1,115 | 47 | HeartFlow, Inc. ($262.52) |
| 2021 | $656.47 | 35 | Amarin Pharma Inc. ($133.32) |
| 2020 | $1,196 | 38 | SANOFI-AVENTIS U.S. LLC ($490.83) |
| 2019 | $953.35 | 36 | Amarin Pharma Inc. ($206.81) |
| 2018 | $1,738 | 43 | SANOFI-AVENTIS U.S. LLC ($821.77) |
| 2017 | $1,377 | 39 | Edwards Lifesciences Corporation ($211.53) |
All Payment Transactions
330 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.12 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $146.01 | General |
| Category: Coronary | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.56 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.09 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: DIABETES | ||||||
| 11/18/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | CORDIS US CORP. | Mynx Venous VCD (Device) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/24/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $101.76 | General |
| Category: Transcatheter Valve Systems | ||||||
| 09/16/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Cardiology | ||||||
| 08/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,480 | 4,441 | $1.3M | $334,161 |
| 2022 | 25 | 3,916 | 5,198 | $1.6M | $426,534 |
| 2021 | 25 | 4,054 | 5,611 | $1.7M | $452,677 |
| 2020 | 21 | 3,526 | 4,844 | $1.5M | $391,445 |
Total Patients
14,976
Total Services
20,094
Medicare Billing
$1.6M
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 525 | 931 | $191,786 | $81,710 | 42.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 265 | 281 | $191,648 | $39,450 | 20.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 117 | 119 | $169,813 | $37,713 | 22.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 599 | 618 | $126,690 | $32,625 | 25.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 102 | 107 | $117,000 | $20,189 | 17.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 208 | 330 | $46,530 | $19,937 | 42.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 107 | 408 | $64,056 | $17,434 | 27.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 99 | 100 | $74,200 | $17,147 | 23.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 94 | $36,942 | $12,314 | 33.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 67 | 67 | $50,116 | $9,032 | 18.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 123 | 123 | $30,219 | $7,309 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $19,200 | $6,678 | 34.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 58 | $15,544 | $5,795 | 37.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 113 | 116 | $32,132 | $5,749 | 17.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 46 | $9,292 | $4,193 | 45.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 99 | 100 | $15,227 | $3,933 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 328 | 388 | $23,280 | $3,732 | 16.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 18 | $5,004 | $2,376 | 47.5% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 232 | 241 | $9,158 | $2,148 | 23.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 99 | 100 | $10,510 | $1,838 | 17.5% |
| 0439T | Ultrasound of heart with injection of x-ray contrast material performed during rest or stress for assessment of heart muscle | Facility | 2023 | 22 | 22 | $5,786 | $1,260 | 21.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 51 | 51 | $2,397 | $549.49 | 22.9% |
| 93307 | Ultrasound of heart | Facility | 2023 | 12 | 12 | $1,728 | $412.04 | 23.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 16 | 17 | $1,190 | $279.10 | 23.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 11 | $913.00 | $216.07 | 23.7% |
About Dr. David Musselman, MD
Dr. David Musselman, MD is a Interventional Cardiology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831137124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Musselman, MD has received a total of $9,817 in payments from pharmaceutical and medical device companies, with $1,883 received in 2024. These payments were reported across 330 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,458).
As a Medicare-enrolled provider, Musselman has provided services to 14,976 Medicare beneficiaries, totaling 20,094 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Plano, TX
- Active Since 06/02/2006
- Last Updated 01/04/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1831137124
Products in Payments
- MULTAQ (Drug) $1,387
- ELIQUIS (Drug) $881.23
- VYNDAQEL (Drug) $566.17
- ENTRESTO (Drug) $532.79
- VERQUVO (Drug) $514.06
- FFRct (Device) $477.14
- LifeVest (Device) $441.18
- Impella (Device) $424.15
- Vascepa (Drug) $413.90
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $336.52
- XARELTO (Drug) $267.53
- Barostim Neo System (Device) $254.75
- Repatha (Biological) $250.31
- FLOWTRIEVER CATHETER, S (Device) $186.24
- Optimizer (Device) $175.85
- PRADAXA (Drug) $175.11
- CAMZYOS (Drug) $164.33
- Arcalyst (Drug) $155.71
- COREVALVE EVOLUT R (Device) $136.40
- ZONTIVITY (Drug) $133.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Plano
Dr. Karim Al-Azizi, M.d, M.D
Interventional Cardiology — Payments: $413,323
Interventional Cardiology $413,323
Molly Szerlip, M.d, M.D
Interventional Cardiology — Payments: $154,405
Interventional Cardiology $154,405
Mohamad Amer Alaiti, M.d, M.D
Interventional Cardiology — Payments: $92,789
Interventional Cardiology $92,789
Obadah Aqtash, Md, MD
Interventional Cardiology — Payments: $27,488
Interventional Cardiology $27,488
Ahmad Zankar, Md, MD
Interventional Cardiology — Payments: $20,465
Interventional Cardiology $20,465
Kalpesh Patel, Md, MD
Interventional Cardiology — Payments: $12,147
Interventional Cardiology $12,147